Algomedix will present at a meeting: Next-Generation Therapeutics for the Treatment of Pain, a Life Science Washington Special Program, April 27, 2017. Dr. Herz will describe progress in the development of TRPA1 antagonists for the treatment of chronic pain.
April 27, 2017
